A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele

Genetic and biochemical studies support the apolipoprotein E (APOE) ε4 allele as a major risk factor for late-onset Alzheimer's disease (AD), though ~50% of AD patients do not carry the allele. APOE transports cholesterol for luteinizing hormone (LH)-regulated steroidogenesis, and both LH and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Haasl, Ryan J, Ahmadi, M Reza, Meethal, Sivan Vadakkadath, Gleason, Carey E, Johnson, Sterling C, Asthana, Sanjay, Bowen, Richard L, Atwood, Craig S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396156/
https://www.ncbi.nlm.nih.gov/pubmed/18439297
http://dx.doi.org/10.1186/1471-2350-9-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396156/
https://www.ncbi.nlm.nih.gov/pubmed/18439297
http://dx.doi.org/10.1186/1471-2350-9-37

Ejemplares similares